Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Jevtana

J&J drug offers hope in advanced prostate cancer

Men with advanced prostate cancer lived nearly four months longer on a new pill from Johnson & Johnson, according to keenly awaited study data that researchers said would change clinical practice.

Abiraterone, which could reach the market next year, provides a new option for men with an aggressive type of prostate cancer.

Its… J&J drug offers hope in advanced prostate cancer   



metabolic evaluation1 - depression2 - permanent kidney damage1 - early risk assessment1 - female incontinence1 - prostate cancer diagnosis1 - kidney tumors1 - urge urinary incontinence5 - infertility2 - chronic urinary tract infections1 - edp1 - crura1 - x chromosome1 - nsaids1 - psa velocity screening1 - microhematuria1 - stenoses1 - routine antenatal sonography1 - hiv1 - fox chase cancer center2 - urea1 - iga nephropathy2 - prognostic indicator1 - kidney fluid filtration1 - short-term hormone therapy1 - kidney abnormality1 - stinky urine1 - desire or erection1 - cancer epidemiology1 - robot-assisted partial nephrectomy1 -